Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Repressor Proteins | 2 | 2015 | 1709 | 0.350 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2021 | 1387 | 0.320 |
Why?
|
| Spliceosomes | 2 | 2021 | 76 | 0.300 |
Why?
|
| Transcription, Genetic | 3 | 2020 | 3324 | 0.260 |
Why?
|
| Supratentorial Neoplasms | 1 | 2021 | 77 | 0.180 |
Why?
|
| Transcription Factor RelA | 1 | 2021 | 184 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 66 | 0.180 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2020 | 103 | 0.170 |
Why?
|
| Gene Amplification | 3 | 2021 | 765 | 0.160 |
Why?
|
| HMGN1 Protein | 1 | 2018 | 3 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2021 | 12056 | 0.160 |
Why?
|
| Immunity | 1 | 2021 | 353 | 0.160 |
Why?
|
| Ependymoma | 1 | 2021 | 264 | 0.160 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 85 | 0.150 |
Why?
|
| Trisomy | 1 | 2018 | 240 | 0.150 |
Why?
|
| Genes, myc | 2 | 2018 | 370 | 0.150 |
Why?
|
| Down Syndrome | 1 | 2018 | 226 | 0.130 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2020 | 467 | 0.130 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 854 | 0.120 |
Why?
|
| Re-Epithelialization | 1 | 2014 | 9 | 0.120 |
Why?
|
| Lipocalins | 1 | 2014 | 54 | 0.120 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 85 | 0.120 |
Why?
|
| Keratinocytes | 1 | 2014 | 242 | 0.110 |
Why?
|
| Wilms Tumor | 1 | 2015 | 301 | 0.110 |
Why?
|
| Proteolysis | 1 | 2014 | 382 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2015 | 1071 | 0.100 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 367 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2018 | 706 | 0.100 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 14875 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 624 | 0.090 |
Why?
|
| Sirolimus | 1 | 2014 | 829 | 0.090 |
Why?
|
| Wound Healing | 1 | 2014 | 746 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 841 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1011 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2015 | 2450 | 0.080 |
Why?
|
| Skin | 1 | 2014 | 1266 | 0.080 |
Why?
|
| Carcinogenesis | 1 | 2014 | 1034 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 4979 | 0.070 |
Why?
|
| Mice | 6 | 2021 | 35449 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 5317 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 1135 | 0.070 |
Why?
|
| Introns | 2 | 2021 | 457 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2020 | 4966 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2021 | 5399 | 0.070 |
Why?
|
| Animals | 8 | 2021 | 61671 | 0.070 |
Why?
|
| Cell Movement | 1 | 2014 | 2472 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2014 | 4911 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2021 | 360 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 2105 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 2605 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 4103 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2021 | 839 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 5775 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 3109 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 106 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 16238 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 151 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 701 | 0.040 |
Why?
|
| Nucleosomes | 1 | 2018 | 150 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 2397 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2015 | 4330 | 0.040 |
Why?
|
| Acetylation | 1 | 2018 | 514 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 132 | 0.040 |
Why?
|
| Lysine | 1 | 2018 | 426 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2015 | 3925 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 23 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 47 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 2454 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1739 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 485 | 0.030 |
Why?
|
| Mutation | 1 | 2015 | 15873 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 3423 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 116 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 125 | 0.030 |
Why?
|
| Genome | 1 | 2018 | 688 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 149 | 0.030 |
Why?
|
| Kinetics | 1 | 2018 | 2215 | 0.030 |
Why?
|
| Oncogenes | 1 | 2018 | 699 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2018 | 1157 | 0.030 |
Why?
|
| Lipocalin-2 | 1 | 2014 | 77 | 0.030 |
Why?
|
| RNA | 1 | 2018 | 1062 | 0.030 |
Why?
|
| Doxycycline | 1 | 2014 | 179 | 0.030 |
Why?
|
| Binding Sites | 1 | 2018 | 2247 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2014 | 33775 | 0.030 |
Why?
|
| Humans | 7 | 2021 | 270884 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2014 | 347 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 547 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 1424 | 0.030 |
Why?
|
| Female | 4 | 2021 | 149013 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 2416 | 0.030 |
Why?
|
| Chromatin | 1 | 2018 | 1044 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 9042 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 1683 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 668 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1075 | 0.020 |
Why?
|
| Histones | 1 | 2018 | 1512 | 0.020 |
Why?
|
| Estradiol | 1 | 2014 | 828 | 0.020 |
Why?
|
| Cell Line | 1 | 2018 | 5328 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 3175 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 873 | 0.020 |
Why?
|
| beta Catenin | 1 | 2014 | 682 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2015 | 1130 | 0.020 |
Why?
|
| Transcriptome | 1 | 2018 | 1960 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 3059 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 1712 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 1537 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 7365 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 7089 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2056 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 6484 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 2177 | 0.020 |
Why?
|
| Apoptosis | 1 | 2021 | 7747 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 3618 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 6230 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 6353 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 5727 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5417 | 0.010 |
Why?
|
| Male | 1 | 2020 | 128379 | 0.010 |
Why?
|